Our client, a global pharmaceutical company, sought to design a best-in-industry external innovation strategy for identifying, capturing and nurturing potentially disruptive innovation ahead of competitors.
Eradigm analysed the external innovation models employed by our client’s competitors, from incubators to crowdsourcing. We evaluated the relative success of competitor strategies to identify key infrastructures, approaches and partnerships that could help our client design an industry-leading external innovation strategy.
